Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 3/20 | 0.37 |
| ▸ | RGS4 | P49798 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 2/20 | 0.33 |
| ▸ | NSD2 | O96028 | 1/20 | 0.31 |
| ▸ | G6PD | P11413 | 1/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8885247 | 0.80 | CCR6 (0.35) | MGLLFAAH | |
| SCHEMBL7830939 | 0.72 | MGLL (0.53) | MGLLFAAHMEN1NPC1RAB9A | |
| SCHEMBL9725345 | 0.72 | FAAH (0.39) | MGLLRGS4FAAHMEN1NPC1 | |
| SCHEMBL11752548 | 0.69 | MGLL (0.63) | MGLLFAAHNSD2G6PDKEAP1 | |
| SCHEMBL18919433 | 0.68 | CMA1 (0.61) | MEN1KMT2A | |
| SCHEMBL18942745 | 0.65 | KMT2A (0.56) | MGLLMEN1KMT2A | |
| SCHEMBL19317166 | 0.62 | MEN1 (0.52) | MEN1RAB9AKMT2AESR1ESR2 | |
| SCHEMBL11883244 | 0.62 | L3MBTL1 (0.44) | MGLLMEN1KMT2A | |
| SCHEMBL17232325 | 0.60 | CCR6 (0.39) | MEN1NPC1RAB9AKMT2A | |
| SCHEMBL11755191 | 0.60 | KMT2A (0.48) | MGLLMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020125546-A1 | CONNECTOR FOR USE IN ANTIBODY MEDICAMENT CONJUGATE AND APPLICATIONS OF CONNECTOR | 荣昌生物制药（烟台）有限公司 | 2020-06-25 | — | — | WO | disclosed |